ContigBio Revenue

Biotechnology Research • Pearland, Texas, United States • 1-10 Employees

ContigBio revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at ContigBio

Maneesh Kumar

Co-Founder, Program Director

Company overview

Headquarters	Pearland, Texas, United States
Website	contigbio.com
NAICS	541714
Keywords	Biotechnology, Biomarkers, Oncology, Drug Development, Bioinformatics, Proteomics, Genomics, Transcriptomics, Translational Research, NGS, Pharmaceutical Research, Single-Cell Transcriptomics, Ai-Driven Drug Discovery, Drug-Discovery, Spatial Genomics
Founded	2023
Employees	1-10

ContigBio Email Formats

ContigBio uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@contigbio.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@contigbio.com	100%

About ContigBio

Contig Bio | Leading Bioinformatics and AI-Driven Drug Discovery Services Contig Bio is a premier provider of bioinformatics solutions, empowering pharmaceutical, biotech companies, and academic institutions with cutting-edge, AI-driven tools for drug discovery and development. Our expertise spans across omics-based studies, offering innovative solutions to streamline complex data analysis and deliver actionable insights. We offer a comprehensive suite of services, including: Genomics, transcriptomics & Proteomics Analysis for single cell and bulk AI-Powered Drug Discovery Our proprietary platform—SWARSH-G, is designed to accelerate research, optimize workflows, and drive innovation. Whether you're advancing early-stage drug discovery or need end-to-end bioinformatics support, our team of seasoned experts will tailor solutions to meet your unique project needs. Why Choose Contig Bio? Over 15 years of individual member expertise in bioinformatics, drug discovery, and computational biology Tailored, flexible solutions for small to large projects AI-powered platforms to enhance decision-making and accelerate R&D Expertise in oncology, immunology, neuroscience, and translational research Let Contig Bio transform your data into breakthrough discoveries. Contact us today to learn how we can partner on your next big challenge. Keywords: Bioinformatics, AI-Driven Drug Discovery, Genomics, Cheminformatics, Computational Biology, Biomarker research, Oncology, Translational Research, Pharmaceutical Research Visit: www.contigbio.com Email: support@contigbio.com

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

ContigBio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

ContigBio has never raised funding before.

ContigBio Tech Stack

Discover the technologies and tools that power ContigBio's digital infrastructure, from frameworks to analytics platforms.

Envoy

Reverse proxies

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

WordPress

Blogs

Google Cloud CDN

CDN

Google Workspace

Sentry

Issue trackers

Sirvoy

Appointment scheduling

WordPress.com

PaaS

React

JavaScript frameworks

Frequently asked questions

ContigBio is located in Pearland, Texas, US.

ContigBio generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

ContigBio has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ContigBio was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

ContigBio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at ContigBio

Maneesh Kumar

Co-Founder, Program Director

4.8

40,000 users